[Image source=Yonhap News]

[Image source=Yonhap News]

View original image


[Asia Economy Reporter Cho Hyun-ui] Donald Trump, the President of the United States, who is hospitalized due to the novel coronavirus infection (COVID-19), received his second dose of the antiviral drug Remdesivir on the 3rd (local time).


Sean Conley, the President's physician, explained in a document sent to White House Press Secretary Kayleigh McEnany that "President Trump completed his second dose of Remdesivir this evening without complications" and "he is gradually improving and doing well since testing positive," according to the American political news outlet The Hill.


Conley reported that President Trump "still has no fever and is not receiving oxygen support," and "spent most of the afternoon working." He added, "Although he is not out of danger yet, the medical team remains cautiously optimistic" and said they will continue to monitor the situation.



President Trump announced on the 2nd that he tested positive for COVID-19 and was transferred to Walter Reed Military Hospital for treatment. In a statement that day, Dr. Conley said that President Trump had started Remdesivir treatment, "completed the first dose, and is resting comfortably."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing